Your browser doesn't support javascript.
loading
Crimean-Congo haemorrhagic fever virus uses LDLR to bind and enter host cells.
Monteil, Vanessa M; Wright, Shane C; Dyczynski, Matheus; Kellner, Max J; Appelberg, Sofia; Platzer, Sebastian W; Ibrahim, Ahmed; Kwon, Hyesoo; Pittarokoilis, Ioannis; Mirandola, Mattia; Michlits, Georg; Devignot, Stephanie; Elder, Elizabeth; Abdurahman, Samir; Bereczky, Sándor; Bagci, Binnur; Youhanna, Sonia; Aastrup, Teodor; Lauschke, Volker M; Salata, Cristiano; Elaldi, Nazif; Weber, Friedemann; Monserrat, Nuria; Hawman, David W; Feldmann, Heinz; Horn, Moritz; Penninger, Josef M; Mirazimi, Ali.
Afiliación
  • Monteil VM; Unit of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • Wright SC; Public Health Agency of Sweden, Solna, Sweden.
  • Dyczynski M; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Kellner MJ; Acus Laboratories GmbH, Cologne, Germany.
  • Appelberg S; JLP Health GmbH, Vienna, Austria.
  • Platzer SW; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Ibrahim A; Vienna Biocenter PhD Program, a Doctoral School of the University of Vienna and the Medical University of Vienna, Vienna, Austria.
  • Kwon H; Public Health Agency of Sweden, Solna, Sweden.
  • Pittarokoilis I; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Mirandola M; Vienna Biocenter PhD Program, a Doctoral School of the University of Vienna and the Medical University of Vienna, Vienna, Austria.
  • Michlits G; Attana AB, Stockholm, Sweden.
  • Devignot S; National Veterinary Institute, Uppsala, Sweden.
  • Elder E; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Abdurahman S; Department of Molecular Medicine, University of Padova, Padova, Italy.
  • Bereczky S; JLP Health GmbH, Vienna, Austria.
  • Bagci B; Unit of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • Youhanna S; Public Health Agency of Sweden, Solna, Sweden.
  • Aastrup T; National Veterinary Institute, Uppsala, Sweden.
  • Lauschke VM; Public Health Agency of Sweden, Solna, Sweden.
  • Salata C; Public Health Agency of Sweden, Solna, Sweden.
  • Elaldi N; Department of Nutrition and Dietetics, Faculty of Health Sciences, Sivas Cumhuriyet University, Sivas, Turkey.
  • Weber F; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Monserrat N; Attana AB, Stockholm, Sweden.
  • Hawman DW; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Feldmann H; University Tübingen, Tübingen, Germany.
  • Horn M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Penninger JM; Department of Molecular Medicine, University of Padova, Padova, Italy.
  • Mirazimi A; Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Cumhuriyet University, Sivas, Turkey.
Nat Microbiol ; 9(6): 1499-1512, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38548922
ABSTRACT
Climate change and population densities accelerated transmission of highly pathogenic viruses to humans, including the Crimean-Congo haemorrhagic fever virus (CCHFV). Here we report that the Low Density Lipoprotein Receptor (LDLR) is a critical receptor for CCHFV cell entry, playing a vital role in CCHFV infection in cell culture and blood vessel organoids. The interaction between CCHFV and LDLR is highly specific, with other members of the LDLR protein family failing to bind to or neutralize the virus. Biosensor experiments demonstrate that LDLR specifically binds the surface glycoproteins of CCHFV. Importantly, mice lacking LDLR exhibit a delay in CCHFV-induced disease. Furthermore, we identified the presence of Apolipoprotein E (ApoE) on CCHFV particles. Our findings highlight the essential role of LDLR in CCHFV infection, irrespective of ApoE presence, when the virus is produced in tick cells. This discovery holds profound implications for the development of future therapies against CCHFV.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas E / Receptores de LDL / Virus de la Fiebre Hemorrágica de Crimea-Congo / Internalización del Virus / Fiebre Hemorrágica de Crimea Límite: Animals / Humans Idioma: En Revista: Nat Microbiol Año: 2024 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas E / Receptores de LDL / Virus de la Fiebre Hemorrágica de Crimea-Congo / Internalización del Virus / Fiebre Hemorrágica de Crimea Límite: Animals / Humans Idioma: En Revista: Nat Microbiol Año: 2024 Tipo del documento: Article País de afiliación: Suecia
...